Posts
August 02 2017
Integrity Applications, Inc. announced the closing of their PIPE offering in the amount of $12,000,000. EG&S acted as counsel to the Placement Agent.
August 01 2017
Industrea Acquisition Corp. announced the closing of its initial public offering in the amount of $230,000,000. EG&S acted as counsel to the underwriters.
July 28 2017
Titan Medical Inc. announced the closing of its registered offering in the amount of $7,356,682. EG&S acted as counsel to Maxim Group LLC, who acted as co-placement agent in the offering.
July 26 2017
Douglas S. Ellenoff, a member of the Firm, was interviewed by Crowdfund Insider on ICOs (Initial Coin Offerings). The Securities and Exchange Commission (SEC) issued an investigative report on the fast-growing Initial Coin Offering market that will squelch the ICO market, at least in the US.
Click here to read the full article.
July 25 2017
Apollo Endosurgery Inc. announced the closing of their Underwritten offering in the amount of $35,983,491. EG&S acted as counsel to the Underwriter.
July 24 2017
ImmunoCellular Therapeutics, Ltd. announced the closing of its public offering in the amount of $5,000,000. EG&S acted as counsel to Maxim Group LLC, the sole book-running manager for the offering.
July 21 2017
Trovagene, Inc., a precision medicine biotechnology company, announced the closing of their Registered Direct offering in the amount of $7.1 million. EG&S acted as counsel to Maxim Group LLC, the Sole Placement Agent for Trovagene.
July 21 2017
Cyclacel Pharmaceuticals Inc. announced the closing of their Underwritten offering in the amount of $4,306,360. EG&S acted as counsel to the Underwriter.